Medicaid Pharmacy Program

Home |  Pharmacy Newsletters Advisories | Live Educational Meetings |   Mental Health Formulary
Corrective Managed Care | Dose Optimization  |  Drug Utilization Review
 Medicaid Prior Authorization & Contact Information |  HealthChoice MCO Information 

Welcome to our website to keep you up to date on Maryland Medicaid Pharmacy Program issues. This website has all of the articles available in the Pharmacy News and Views Newsletter, and links to the Maryland Medicaid Pharmacy Program Advisories and Program website.

Live Educational Meetings

Continuing Medical Education and
Continuing Education Seminar

Updates in Treatment Strategies for Complicated Disease States: Substance Abuse Disorder and Hepatitis C  

Saturday, October 24, 2015
7:30 am Registration and Breakfast
8:30 am - 1 pm Seminar

St. Agnes Hospital, Baltimore, MD

Register Here



Substance Use Disorder

  • Increase knowledge of epidemic of opiate use disorder.

  • Increase knowledge of treatment of opiate use disorder.

  • Define “clinical integration” related to substance use disorders.

  • List self-reported physician barriers to prescribing buprenorphine.

  • Describe a model of treatment that links opioid treatment programs with office-based buprenorphine prescribers.

  • Be convinced that integrating treatment for opiate use disorder with medical care is beneficial (for patient, providers and the health system).

Hepatitis C

  • Discuss the prevalence, natural history and healthcare impact of Hepatitis C.

  • Review the recent advances in treatment of Hepatitis C.

  • Explore financial consideration and public health impact of new therapies for Hepatitis C.

  • Discuss the selection of appropriate HCV oral direct acting therapy and duration of therapy in HCV/HIV co-infected patients.

  • Recognize antiretroviral management issues in HIV/HCV co-infected patients including drug-drug interactions.

  • Discuss monitoring of patients on HCV therapy.


  • Integrating Buprenorphine Treatment of Opiate Use Disorder into Primary Care
    Michael Fingerhood, MD FACP, Director, Division of Chemical Dependence, Johns Hopkins Bayview Medical Center

  • CoOP: A Collaborative Care Model Linking Office-Based Buprenorphine Prescribers with Specialty Treatment Clinics
    Kenneth B Stoller, MD, Director and Medical Director for Behavioral Health, Johns Hopkins Broadway Center for Addictions  

  • Hepatitis C: The Future is Here
    Darryn Potosky, MD, Director of Hepatology, University of Maryland School of Medicine

  • Hepatitis C Management in the HIV Infected Patient
    Oluwaseun Falade-Nwulia, MBBS, MPH, Medical Director, Baltimore City Health Department, STD Clinic/HIV Early Intervention Initiative Program

Program Sponsorship

This program is co-sponsored by, the Maryland Department of Health and Mental Hygiene (DHMH), Maryland Medicaid Pharmacy Program (MMPP), Saint Agnes Hospital, Inc. and Health Information Designs, LLC. 


Education Credits

A maximum of 4 CME and ACPE credits will be available for this program. For ACPE credits, pharmacists must provide a valid NABP#


Registration is Open

Attendees must register online here. There is no charge for attending the seminar. Priority registration will be given to prescribers until 10/5/15. For details call 410-767-5945. 


   Copyright HID/MMPP ~ Contact web administrator

Maryland Medicaid Pharmacy Program

Preferred Drug List

The Maryland Medicaid Pharmacy Program Preferred Drug List (PDL) is included on Epocrates. Visit Epocrates and click on "Epocrates Online" or "My Account" to register for your free Epocrates online account. The PDL is updated weekly.

Maryland Department of Health and Mental Hygiene

Maryland Medicaid Pharmacy Program Provider Advisories

Maryland Medicaid Provider Transmittals

Maryland Board of Pharmacy

This website is maintained by Health Information Designs Inc., which is under contract with the Department of Health and Mental Hygiene (DHMH) to provide technical support  for the Maryland Medicaid Pharmacy Program. Links to the DHMH Maryland Medicaid Pharmacy Program and other DHMH websites are provided.  Questions concerning this website should be directed to the website administrator.